期刊文献+

系统性硬化症动物模型 被引量:1

Animal Models of Systemic Sclerosis
下载PDF
导出
摘要 系统性硬化症是一种自身免疫病,以多系统纤维化、小血管病变、血清自身抗体阳性为主要特点。目前其病因尚未十分清楚,越来越多的证据显示可能有血管病变、炎性反应、纤维化、自身免疫四大机制参与并相互作用。在研究系统性硬化症的发病机制、探索新药治疗效果时需要用到动物模型来模拟病理生理过程,而每一种模型都有其特点却又不完美。本文将根据建模方法分类介绍一些经典的和创新的模型,以及它们各自的特点、应用价值,为研究者选择最合适的动物模型提供帮助。 Systemic sclerosis,a chronic autoimmune disorder,is characterized by tissue fibrosis,vasculopathy and the presence of serum autoantibodies. Although the etiology has not been fully elucidated yet,many evidence have shown that the participation and interaction of vascular injury,inflammation,fibrosis and immunological abnormalities to exist in patients with systemic sclerosis. Animal models are indispensable tools for pathogenesis investigation and new drug development,but not a single model is perfect in imitating all aspects of systemic sclerosis so far. This review introduced both widely-used and newly-created animal models. The pathophysiologic features and applications will be focused in order to help investigators choosing an appropriate model for research.
作者 罗妍 王迁
出处 《中华临床免疫和变态反应杂志》 2014年第3期248-253,F0003,共7页 Chinese Journal of Allergy & Clinical Immunology
关键词 系统性硬化症 硬皮病 动物模型 博来霉素 systemic sclerosis scleroderma animal model bleomycin
  • 相关文献

参考文献35

  • 1Kelley WN.Kelley's textbook of rheumatology[M].Elsevier Health Sciences,2012.
  • 2李梦涛,侯勇,雷云霞,张巍,孙秋宁,曾小峰.合作与发展:系统性硬化症的未来——第一届国际系统性硬化症会议纪要[J].中华临床免疫和变态反应杂志,2010,4(2):151-154. 被引量:2
  • 3Aso Y,Yoneda K,Kikkawa Y.Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice[J].Lab Invest,1976,35:558-568.
  • 4Yamamoto T,Takagawa S,Katayama I,et al.Animal model of sclerotic skin.I:Local injections of bleomycin induce sclerotic skin mimicking scleroderma[J].J Investigative Dermatol,1999,112:456-462.
  • 5Yamamoto T,Kuroda M,Nishioka K.Animal model of sclerotic skin.III:Histopathological comparison of bleomycin-induced scleroderma in various mice strains[J].Arch Dermatol Res,2000,292:535-541.
  • 6Batteux F,Kavian N,Servettaz A.New insights on chemically induced animal models of systemic sclerosis[J].Curr Opin Rheumatol,2011,23:511-518.
  • 7Yoshizaki A,Iwata Y,Komura K,et al.CD19regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma[J],Am J Pathol,2008,172:1650-1663.
  • 8Kitaba S,Murota H,Terao M,et al.Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma[J].Am J Pathol,2012,180:165-176.
  • 9Okamoto Y,Hasegawa M,Matsushita T,et al.Potential roles of interleukin-17A in the development of skin fibrosis in mice[J].Arthritis Rheum,2012,64:3726-3735.
  • 10Luzina IG,Kopach P,Lockatell V,et al.Interleukin-33 potentiates bleomycin-induced lung injury[J].Am J Respir CeU Mol Biol,2013,49:999-1008.

共引文献1

同被引文献26

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部